Novo Nordisk (NVO) has reportedly settled a lawsuit filed by the state of Minnesota over the pricing of its insulin products by agreeing to cap costs at $35 per month.

Patients to pay no more than $35 a month Eli Lilly, Sanofi previously settled overcharging claims Novo Nordisk denies wrongdoing, pledges affordable insulin ... Minnesota's case began in 2018 ...

The settlement resolves the Attorney General’s 2018 lawsuit alleging that Novo Nordisk deceptively priced its insulin.

Novo Nordisk agreed to cap insulin prices to settle a lawsuit in which Minnesota's attorney general accused the three largest ...

Novo Nordisk agreed to cap insulin prices to settle a lawsuit in which Minnesota's attorney general accused the three largest ...

In absolute terms, there were 0.73 cases of hypoglycaemia per year with insulin icodec, versus 0.27 events for the once-daily drug. Novo Nordisk said that if approved for use, insulin icodec would ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

Diabetes specialist Novo Nordisk is feeling the heat ... was founded on successive innovation in insulin products and user-friendly insulin pen devices. The company also expanded into haemophilia ...

Pictured is an insulin pen manufactured by the Novo Nordisk company on March 14 ... the list price of certain insulins has increased in some cases by more than 1,000%, according to the lawsuit.

Novo Nordisk A/S on Monday became the final insulin manufacturer to reach a proposed settlement agreement with Minnesota, tentatively ending a seven-year lawsuit over the affordability of the diabetes ...